biocept 产品代理
biocept 产品代理
使用我们的检测服务分析和询问某些生物标记物的CTC和ctDNA，医生可以更好地了解与患者癌症相关的可操作分子信息。因为我们使用一个简单的血液样本，这种分子信息可以非侵入性地获得，比组织活检更快。
此外，对于之前诊断为癌症的患者，当组织活检不充分或不可能时，我们的液体活检测试提供了解决方案。使用我们专有的液体活检检测服务，医生可以通过简单的血液检测获得为患者制定个性化癌症治疗计划所需的信息。
Biocept的服务面向内科和外科肿瘤学家、病理学家、医院、癌症中心、大学、制药和临床研究人员。我们的液体活组织检查已被医生用于数千例患者。我们与行业领导者和主要癌症中心合作，不断推进癌症诊断领域。
CNSide™
CEE-Sure Blood Collection Tube
Target Selector Kits (US)
EGFR Mutation Test Kit
BRAF Mutation Test Kit
Target Selector Kits for CE Countries Only
EGFR Test Kit
Target Selector NGS Panels
NGS Lung Panel
NGS Breast Panel
We have developed a unique, patented methodology to isolate cancer material that is shed into the bloodstream, such as circulating tumor cells, (CTCs) and cell-free circulating tumor DNA (ctDNA).
Using our testing service to analyze and interrogate CTCs and ctDNA for certain biomarkers, physicians can be better informed about the actionable molecular information associated with a patient’s cancer. Because we use a simple blood sample, this molecular information can be obtained non-invasively and more rapidly than a tissue biopsy.
Additionally, in patients previously diagnosed with cancer, our liquid biopsy tests offer a solution when a tissue biopsy is insufficient or not possible. Using our proprietary liquid biopsy testing service, physicians can obtain information they need to develop a personalized cancer treatment plan for their patients—all from a simple blood test.
Biocept’s services are available to medical and surgical oncologists, pathologists, hospitals, cancer centers, universities, and pharmaceutical and clinical researchers. Our liquid biopsies have been used by doctors in thousands of patient cases. We partner with industry leaders and major cancer centers, continually advancing the field of cancer diagnostics.
